Search

PVPHARM, a leading company in specialized pharmacovigilance and clinical safety services, has a group of experts that can manage CTIS on behalf of any clinical trial sponsor, and related tasks

The company plans to continue pushing forward the development of in silico enzyme discovery and design projects in the United States, especially in the area of the Life Sciences

Oryzon and NCI will collaborate to assess the safety and efficacy of iadademstat in oncology patients with different hematological and solid tumors

Almirall recently announced topline results from one-year analyses of the efficacy and safety of lebrikizumab, an investigational IL-13 inhibitor for the treatment of patients with moderate-to-severe

The event made public the winning projects that put the patient at the centre of the healthcare system unveiled

The analysis focuses on genomic data provided by various genomic technologies

BCN HEALTH presents the poster "Increased baseline comorbidity burden including liver severity among HDV/HBV coinfection versus HBV monoinfection patients – analysis from National Hospital Discharge

Extension led by Pfizer with participation from new investors Walleye Capital and Asabys Partners as well as existing investors

The Venture Centre of Excellence, a public-private co-investment programme of EIT Health and the European investment Fund (EIF) to empower finance for European health small and medium size enterprises

Mucormycosis is a difficult to treat invasive fungal infection with high mortality

The AseBio 2021 Report was presented at ICEX in Madrid on Thursday, with the support of Merck, thanks to a journey through 13 of the 17 SDGs on which biotechnology has a direct impact. The document

Funding provided by Nice & Green SA, a Swiss institutional investor

Medmesafe, expands its portfolio of associated companies and, with more than 150, is the online platform with the largest network of laboratories in Spain

BCN HEALTH has published the study ‘Hospital incidence and costs of congenital hydrocephalus in Spain: a multicenter retrospective study’ in the journal ‘Expert Review of Pharmacoeconomics & Outcomes

Peregrín, has signed a MAAVi Lab or strategic partnership agreement with Kimitec under which both companies will cooperate to develop the most sustainable garlic on the market by 2030